Synjardy XR 1000 mg/1

Synjardy XR 1000 mg/1 combines empagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes. Learn about Synjardy XR uses, effects, and precautions.

Synjardy XR 1000 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. It combines empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and metformin hydrochloride, a biguanide. This combination is often used when diet and exercise alone are not enough to control blood glucose. People may ask, 'What is Synjardy XR used for?' It is typically prescribed as part of a broader diabetes management plan.

Common effects of Synjardy XR 1000 mg/1 may include gastrointestinal symptoms like diarrhea, nausea, or vomiting, particularly when first starting the medication. Some users may experience urinary tract infections or genital mycotic infections. These effects vary by individual and are not exhaustive. Always consult a healthcare provider for personalized advice.

Synjardy XR 1000 mg/1 should be handled with care, especially for those with kidney issues, as empagliflozin affects kidney function. Metformin can cause lactic acidosis in rare cases, particularly in people with severe kidney problems. It's important to follow medical guidance regarding its use. Always store the medication as directed and keep it out of reach of children.

Synjardy XR 1000 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol can increase the risk of lactic acidosis with metformin. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. This includes over-the-counter drugs, supplements, and herbal products.